Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 2,886,489 | 2,177,199 | 1,456,601 | 728,013 | 2,531,135 |
| Accounts payable and accrued liabilities | -2,127,939 | -1,597,938 | -1,131,533 | -612,803 | -1,877,344 |
| Other Working Capital | 621,616 | 473,511 | 245,959 | 100,174 | 566,908 |
| Other Operating Activity | -710,702 | -554,175 | -302,793 | -101,774 | -635,727 |
| Operating Cash Flow | $669,464 | $498,597 | $268,234 | $113,610 | $584,972 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -538,171 | -152,443 | -105,682 | -28,792 | 119,601 |
| PPE Investments | -133,694 | -77,511 | -42,922 | -19,535 | -108,494 |
| Net Acquisitions | -125,516 | N/A | N/A | N/A | -84,415 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 3,414 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 3,414 |
| Investing Cash Flow | $-797,381 | $-229,954 | $-148,604 | $-48,327 | $-69,894 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -3,020 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -1,645 | -1,523 | -1,401 | -426,938 |
| Common Stock Issued | 20,632 | 14,460 | -41,891 | 4,052 | 20,198 |
| Common Stock Repurchased | -49,998 | -49,998 | N/A | -49,998 | -100,004 |
| Other Financing Activity | -23,043 | -22,881 | -1,068 | 0 | -16,297 |
| Financing Cash Flow | $-55,429 | $-60,064 | $-44,482 | $-47,347 | $-523,041 |
| Exchange Rate Effect | -12,636 | -11,174 | -5,102 | -7,347 | 12,427 |
| Beginning Cash Position | 667,115 | 667,115 | 667,115 | 667,115 | 662,651 |
| End Cash Position | 471,133 | 864,520 | 737,161 | 677,704 | 667,115 |
| Net Cash Flow | $-195,982 | $197,405 | $70,046 | $10,589 | $4,464 |
| Free Cash Flow | |||||
| Operating Cash Flow | 669,464 | 498,597 | 268,234 | 113,610 | 584,972 |
| Capital Expenditure | -133,746 | -77,563 | -42,935 | -19,547 | -108,564 |
| Free Cash Flow | 535,718 | 421,034 | 225,299 | 94,063 | 476,408 |